The use of adenoviral vectors for gene therapy and gene transfer in vivo.
about
High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene TherapyRe-engineering the functions of a terminally differentiated epithelial cell in vivo.Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.In vivo gene transfer to salivary glands.Improvements in adenoviral vector technology: overcoming barriers for gene therapy.Gene therapy for paediatric leukaemia.In situ gene therapy for prostate cancer: immunomodulatory approaches.Current strategies and future directions for eluding adenoviral vector immunityEncapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response.Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging.A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemiaInflammation induced by MMP-9 enhances tumor regression of experimental breast cancerGene therapy for colorectal cancer using adenovirus-mediated full-length antibody, cetuximab.Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses.Modeling hepatitis B virus infection, immunopathology and therapy in mice.Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.The Scope of Viral Vectors for the Transduction of Haemopoietic Cells.Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector.Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.Construction of an adenovirus type 7a E1A- vector.Development of an Ad7 cosmid system and generation of an Ad7deltaE1deltaE3HIV(MN) env/rev recombinant virus.Construction and characterization of a replication-deficient adenovirus expressing rat-soluble interleukin-6 receptor.Adenovirus-vector-mediated cytokine gene transfer to lung tissue.Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils.Gene therapy for lung inflammatory diseases: not so far away?Cytokine regulation of epithelial permeability and ion transport.Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism.Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B.Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A mice.Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin.New prospects for cardiovascular gene therapy.Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis
P2860
Q33670765-4087B3B8-2106-458F-B1A1-7841E212469DQ33692594-40AD8DB2-78F6-461A-98D3-9E99D2C71194Q33818929-50055E74-356E-4195-9B24-56A2A85842D3Q33851759-8B3F3FAB-A6D6-4975-906E-021AAB4B0455Q33888253-45494529-F1F3-4E28-A812-94702AF21F24Q34005922-F0DF83E2-6089-4AC8-B19F-C95B74CC4A26Q34451905-4747560B-BF04-42C8-BF6E-FE7B0366BC60Q34452001-B3F72523-1FCB-4E8A-9D5B-9D2608BC1546Q34585554-E92034BE-1AED-4542-9925-5EFE9AA70A50Q34600592-8D8AE146-7D4C-494D-A22D-26F17390045DQ34658351-78B2FC02-199B-4A1F-8249-80721382BA17Q35881805-53B10B03-AAB1-4FFB-96D8-3AE5833978E0Q35915922-6F60664A-B84A-4341-9D62-C9547D655579Q36455873-572FDFBA-751A-4978-8ADA-6DC58436B1E1Q36748236-CFF1FCA5-93A6-4755-84AE-661C115D9524Q37317530-31F757F8-F687-4BBB-A7EA-608360B41250Q38121577-66A28398-E012-4155-9838-FA04E047063CQ38534533-C89B4A66-71DF-48C3-A1CD-222EFE404525Q38848060-A5E30F22-B306-4E59-AD6D-78651F7BD7D2Q38896599-C2129C15-456E-4CB3-BBAB-A8998F8E6C16Q39549150-7786D616-ACAC-4D46-9F5B-5F86A6BB3F81Q39580779-5F6A2BAD-2AFE-4400-B3D0-C1EB6B7146A3Q39876527-8239488D-DF91-4B17-B21A-7A810A8B15D1Q39882405-BF9E5F56-0759-4D5C-BAC7-E002FA6D3D62Q40669254-C21183FE-993C-40D4-93DE-CB6A6A06AD74Q41095775-729DB8DD-D6B8-4B32-A4B8-A0EF23FB4A8CQ41200727-52673EE8-C487-429B-BF89-9AD5DBF8C42BQ41459111-5E179B85-4CAF-4465-89A6-7BEE761E17BBQ41854085-E736A5CB-3646-4248-85AF-FBDB9ECBA254Q43087214-164199B7-2041-413C-B175-0B83DF1B58F8Q43501937-4EAB46CF-B67A-4F77-AD7E-4EED866E741BQ44386816-21D8CDCA-1277-42E8-AB1A-937037EE2EE8Q45871591-BA78F9E9-A5CC-4DFC-8452-B1D0AC8CB215Q45873999-04DDD6AC-77B8-44A1-BDCC-F289B9586DF6Q45884606-B79F2E67-CD35-4A6A-BAE7-5B8A9BA2488CQ56905891-67A5CDE0-0612-4CD0-823C-DD3EC4AB42EB
P2860
The use of adenoviral vectors for gene therapy and gene transfer in vivo.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The use of adenoviral vectors for gene therapy and gene transfer in vivo.
@en
type
label
The use of adenoviral vectors for gene therapy and gene transfer in vivo.
@en
prefLabel
The use of adenoviral vectors for gene therapy and gene transfer in vivo.
@en
P2093
P1476
The use of adenoviral vectors for gene therapy and gene transfer in vivo.
@en
P2093
P304
P356
10.1016/0958-1669(95)80097-2
P577
1995-10-01T00:00:00Z